We're going to move right on to public comment session.

We want you to know that you are very important to us, that your thoughts and concerns are taken into consideration, and we welcome them.

So we'll begin, Mr. Dell Big Tree.

Would you please come to the microphone state, your name, and your affiliated organization.

My name is Dell Big Tree.

I speak for the important consent action network, which is my nonprofit.

I would like to address our concerns about the safety trials that are taking place on all of the vaccines for COVID-19.

Specifically, I want to point out that I think the ASIP committee that you sit in an unprecedented moment of the potential of having one of the greatest accidents and science that is ever taken place.

And that would be rushing this vaccine, given what we know about the science.

Of course, I'm talking about the possibility for antibody dependent enhancement, complement mediated antibody dependent enhancement, cellular mediated enhancement, TH2, all of these problems, which have appeared in dengue backs, which killed over 100 people in the dengue backs campaign, the Philippines, the RSV vaccine program, which was discontinued because of the death of children.

And this occurring in virtually every animal trial over the last 20 years.

This is not any other vaccine.

This is one of the most dangerous vaccines ever attempted.

And to know that we are using warp speed and that we have governors around this country and leaders around the world saying they will immediately mandate this product upon all of their population.

Means that we could have a vaccine that could potentially kill unknown, untold amounts of people because their bodies don't detect them after this vaccine, but in fact enhance the problem.

And when I look at the trials that are taking place, when we look at the Moderna trials, we are not doing challenge studies on human beings, but the challenge studies being done on Maccach monkeys, which are known to have a very mild reaction, which is not the way to, you know, to weed out a problem.

We're using the young monkeys and even then we did not test them.

We did not challenge them in the first after the first vaccine, which only created binding antibodies, which is one of the theories that creates the immune enhancement.

We only tested after they knew they had neutralizing antibodies, which only took place two weeks after the booster shot, which means we are allowing the pharmaceutical industry to cherry pick their moments of research to make their vaccine look good.

Of course, they're going to try and make it look good.

They stand to make potentially hundreds of billions of dollars.

If not billions of dollars off of the vaccine, should they be selected under these circumstances?

...